-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Infectious Diseases Sessions

Saturday, December 7, 2024

top

9:00 AM-7:30 PM


Poster Session I - Viewing  
Events

11:15 AM-12:15 PM


Career Development Lunch
Trainee Activities and Services

12:00 PM-1:30 PM


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Know Thy(mus) Self, Know Thy Enemy: From Lymphocyte Genetic Variation to Disease  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Humoral Coagulation Factors: Venous Thrombosis and Beyond  
Oral and Poster Abstracts

2:00 PM-3:30 PM


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Platelets and Endothelium in Thrombotic Disorders  
Oral and Poster Abstracts


907. Outcomes Research: Plasma Cell Disorders: Quality Matters and Key Outcomes in Multiple Myeloma  
Oral and Poster Abstracts

5:30 PM-7:30 PM


Poster Session I - Presentations (for in-person participants)  
Events


113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I  
Oral and Poster Abstracts


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster I  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster I  
Oral and Poster Abstracts


652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


653. Multiple Myeloma: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I  
Oral and Poster Abstracts


722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I  
Oral and Poster Abstracts


802. Chemical Biology and Experimental Therapeutics: Poster I  
Oral and Poster Abstracts


902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I  
Oral and Poster Abstracts


907. Outcomes Research: Plasma Cell Disorders: Poster I  
Oral and Poster Abstracts

Sunday, December 8, 2024

top

9:00 AM-8:00 PM


Poster Session II - Viewing  
Events

4:30 PM-6:00 PM


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Risk Adapted Approaches to Reduce Transplant Related Toxicities  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session II - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster II  
Oral and Poster Abstracts


201. Granulocytes, Monocytes, and Macrophages: Poster II  
Oral and Poster Abstracts


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II  
Oral and Poster Abstracts


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Poster II  
Oral and Poster Abstracts


615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


621. Lymphomas: Translational – Molecular and Genetic: Poster II  
Oral and Poster Abstracts


623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


626. Aggressive Lymphomas: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II  
Oral and Poster Abstracts


722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II  
Oral and Poster Abstracts


902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster II  
Oral and Poster Abstracts


906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II  
Oral and Poster Abstracts

Monday, December 9, 2024

top

9:00 AM-8:00 PM


Poster Session III - Viewing  
Events

4:30 PM-6:00 PM


101. Red Cells and Erythropoiesis, Excluding Iron: Erythropoiesis in Disease  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session III - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster III  
Oral and Poster Abstracts


114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster III  
Oral and Poster Abstracts


624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III  
Oral and Poster Abstracts


908. Outcomes Research: Myeloid Malignancies: Poster III  
Oral and Poster Abstracts